1-4 of 4
Raymond Yin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA (ctDNA) Enables Superior and Universal Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) Highly Predictive of Relapse Free and Overall Survival

Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Sky Kim, Kailee Tanaka, Sanjeeth Rajaram, Mia Carleton, Raymond Yin, Matthew Alkaitis, Matthew Schwede, Brian J. Sworder, Michael S. Khodadoust, Ravi Majeti, David Kurtz, Tian Y Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 2955.
https://doi.org/10.1182/blood-2024-201701
Published: 2024
Journal Articles

Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)

Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Matthew Schwede, Kailee Tanaka, Matthew Alkaitis, Raymond Yin, Brian J. Sworder, Gabriel Mannis, Ravindra Majeti, Michael S. Khodadoust, David M. Kurtz, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4307.
https://doi.org/10.1182/blood-2023-181459
Published: 2023
Journal Articles

Heterogeneous Definitions of Secondary Acute Myeloid Leukemia (AML) Yield Distinct Outcomes in Response to First-Line Treatment with Hypomethylating Agents (HMA) and Venetoclax (Ven)

Irena Tan, Matthew Schwede, Paul Phan, Raymond Yin, Tian Y Zhang, Gabriel N. Mannis
Journal: Blood
Blood (2021) 138 (Supplement 1): 1216.
https://doi.org/10.1182/blood-2021-147886
Published: 2021
Journal Articles

Enasidenib Drives Maturation of Human Erythroid Precursors Independently of IDH2

Ritika Dutta, BS, Tian Y Zhang, MD PhD, Thomas Koehnke, MD, Daniel Thomas, MD PhD, Eric Gars, MD, Melissa Stafford, Yusuke Nakauchi, MD PhD, Satinder Kaur, BS, Raymond Yin, Anupama Narla, MD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 540.
https://doi.org/10.1182/blood-2019-124551
Published: 2019